Markus Kalousek

Markus Kalousek is a Venture Partner at BGV (BioGeneration Ventures) and serves as Chair of the Healthcare Investment Committee as well as an Advisor at Sixty Degree Capital. Additionally, Markus holds the position of Chairman of the Board at FimmCyte and is a Board Member at Red Ridge Bio. In the academic sphere, Markus is a Lecturer in Translational Medicine at ETH Zürich. Markus earned a PhD in Cancer Biology from ETH Zürich and completed a postdoctoral fellowship in Cancer Biology at the National University of Singapore.